5.05
price up icon3.48%   0.17
after-market Handel nachbörslich: 5.37 0.32 +6.34%
loading
Schlusskurs vom Vortag:
$4.88
Offen:
$4.91
24-Stunden-Volumen:
300.07K
Relative Volume:
1.33
Marktkapitalisierung:
$216.56M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-19.90M
KGV:
-9.5283
EPS:
-0.53
Netto-Cashflow:
$-19.80M
1W Leistung:
+20.81%
1M Leistung:
+27.85%
6M Leistung:
-19.84%
1J Leistung:
+36.86%
1-Tages-Spanne:
Value
$4.81
$5.25
1-Wochen-Bereich:
Value
$4.1518
$5.25
52-Wochen-Spanne:
Value
$3.19
$6.8184

Diamedica Therapeutics Inc Stock (DMAC) Company Profile

Name
Firmenname
Diamedica Therapeutics Inc
Name
Telefon
(763) 496-5454
Name
Adresse
301 CARLSON PARKWAY, MINNEAPOLIS, MN
Name
Mitarbeiter
28
Name
Twitter
@diamedica
Name
Nächster Verdiensttermin
2025-03-17
Name
Neueste SEC-Einreichungen
Name
DMAC's Discussions on Twitter

Vergleichen Sie DMAC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
DMAC
Diamedica Therapeutics Inc
5.05 251.27M 0 -19.90M -19.80M -0.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Diamedica Therapeutics Inc Stock (DMAC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-10-07 Eingeleitet H.C. Wainwright Buy
2024-04-24 Fortgesetzt Craig Hallum Buy
2023-06-22 Hochstufung Oppenheimer Perform → Outperform
2021-04-09 Eingeleitet Oppenheimer Outperform
2021-02-17 Eingeleitet ROTH Capital Buy
2020-10-30 Eingeleitet Guggenheim Buy
2020-07-08 Eingeleitet Maxim Group Buy
2019-04-30 Eingeleitet Dougherty & Company Buy
2019-03-05 Eingeleitet Lake Street Buy
Alle ansehen

Diamedica Therapeutics Inc Aktie (DMAC) Neueste Nachrichten

pulisher
07:20 AM

What drives DiaMedica Therapeutics Inc. stock priceRapidly growing investment returns - PrintWeekIndia

07:20 AM
pulisher
01:41 AM

DiaMedica gains on positive mid-stage trial data for lead drug in preeclampsia - MSN

01:41 AM
pulisher
01:25 AM

DiaMedica Therapeutics Inc. Stock Analysis and ForecastFree Market Volatility Navigation Tips - PrintWeekIndia

01:25 AM
pulisher
Jul 24, 2025

Is DiaMedica Therapeutics Inc. stock overhyped or has real potentialBreakthrough financial growth - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

DiaMedica raises $30.1M in private placement for preeclampsia, stroke treatment - The Business Journals

Jul 24, 2025
pulisher
Jul 24, 2025

The Beat: Entrust names new CEO, DiaMedica raises millions - The Business Journals

Jul 24, 2025
pulisher
Jul 24, 2025

DiaMedica Therapeutics Announces Closing of $30.1 Million Private Placement - BioSpace

Jul 24, 2025
pulisher
Jul 23, 2025

DiaMedica Therapeutics Secures $30.1 Million in Private Placement - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

DiaMedica Therapeutics closes $30.1 million private placement - Investing.com India

Jul 23, 2025
pulisher
Jul 23, 2025

DiaMedica Therapeutics closes $30.1 million private placement By Investing.com - Investing.com UK

Jul 23, 2025
pulisher
Jul 22, 2025

Is DiaMedica Therapeutics Inc. a good long term investmentDynamic profit expansion - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about DiaMedica Therapeutics Inc. stockFree Stock Market Knowledge Sharing - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Diamedica Therapeutics shares rise 11.01% intraday after $30.1M private placement and positive trial results for DM199 in preeclampsia. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

DiaMedica Therapeutics to sell 8.606M shares at $3.50 in private placement - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

DiaMedica Announces $30.1M Private Placement for DM199 - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

DiaMedica secures $30.1 million in private placement for clinical trials By Investing.com - Investing.com South Africa

Jul 21, 2025
pulisher
Jul 21, 2025

DiaMedica secures $30.1 million in private placement for clinical trials - Investing.com

Jul 21, 2025
pulisher
Jul 21, 2025

User - FinancialContent

Jul 21, 2025
pulisher
Jul 21, 2025

DiaMedica Therapeutics (NASDAQ:DMAC) Price Target Raised to $12.00 - Defense World

Jul 21, 2025
pulisher
Jul 20, 2025

DiaMedica shares drop 35% following InvestingPro’s overvalued warning By Investing.com - Investing.com India

Jul 20, 2025
pulisher
Jul 18, 2025

What makes DiaMedica Therapeutics Inc. stock price move sharplyReliable High Profit Alerts - beatles.ru

Jul 18, 2025
pulisher
Jul 18, 2025

DiaMedica stock price target raised to $12 from $10 at H.C. Wainwright - Investing.com

Jul 18, 2025
pulisher
Jul 17, 2025

DiaMedica Therapeutics to be included in the Russell 2000 and 3000 indexes - MSN

Jul 17, 2025
pulisher
Jul 17, 2025

DiaMedica Therapeutics Reports Positive Interim Phase 2 Preeclampsia Results: Statistically Significant Reductions in Blood Pressure and No Placental Transfer - BioSpace

Jul 17, 2025
pulisher
Jul 17, 2025

DiaMedica Therapeutics reports interim results from DM199 study - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

DiaMedica Announces Positive Interim Results for DM199 Study - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

DiaMedica reports positive interim results for preeclampsia treatment - Investing.com

Jul 17, 2025
pulisher
Jul 15, 2025

Why DiaMedica Therapeutics Inc. stock attracts strong analyst attentionVerified Return Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How DiaMedica Therapeutics Inc. stock performs during market volatilityValue Pick Scanner - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

3 Promising Penny Stocks With Market Caps Under $200M - simplywall.st

Jul 15, 2025
pulisher
Jul 01, 2025

Trend Tracker for (DMAC) - news.stocktradersdaily.com

Jul 01, 2025
pulisher
Jun 30, 2025

DiaMedica Therapeutics Inc.(NasdaqCM: DMAC) added to Russell 2000 Dynamic Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

DiaMedica Therapeutics Inc.(NasdaqCM: DMAC) added to Russell 3000 Growth Index - MarketScreener

Jun 30, 2025

Finanzdaten der Diamedica Therapeutics Inc-Aktie (DMAC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Kapitalisierung:     |  Volumen (24h):